Showing results (41-50 of 166) with videos related to

Sort By:
Pageof 17
European Journal of Haematology|January 15, 2009
Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomasHeidi Nyman, Mats Jerkeman, Marja-Liisa Karjalainen-Lindsberg, et al.
Pharmacoepidemiology and Drug Safety|January 12, 2021
Detecting deviations from the efficacy and safety results of single-arm trials using real-world data: The case of a CAR-T cell therapy in B-cell lymphomaLasse Hjort Jakobsen, Torbjörn Callréus, Maurizio Sessa, et al.
Acta Oncologica (Stockholm, Sweden)|April 22, 2026
Feasibility of patient-reported outcomes collection in clinical routine at a radiotherapy departmentIngrid Fagerström Kristensen, Anton Linnér, Martin Nilsson, et al.
Experimental Hematology & Oncology|May 15, 2015
Pharmacologically relevant doses of valproate upregulate CD20 expression in three diffuse large B-cell lymphoma patients in vivoJesper Kofoed Damm, Sandra Gordon, Mats Ehinger, et al.
Blood Advances|August 16, 2022
Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantationSara Ekberg, Karin E Smedby, Alexandra Albertsson-Lindblad, et al.
Scientific Reports|August 28, 2025
Assessing the feasibility of HPV screening for cervical cancer in pregnant women in EthiopiaSelamawit Mekuria, Nahom Assiged, Habtamu Biazin, et al.
International Journal of Cancer|February 14, 2025
High-risk human papillomavirus genotypes in previously unscreened reproductive-age women in Ethiopia: A community-based cohort studyHabtamu Biazin Kebede, Selamawit Mekuria, Nahom Asegid, et al.
Pageof 17